GMS-CDC

News

Vaccine against burkholderia infections

PDF Print E-mail
Wednesday, 10 March 2010 16:10
Abstract: This invention relates to proteins expressed by ABC system genes of Burkholderia pseudomallei. The proteins (or protective fragments or protective variants thereof) are protective against Burkholderia pseudomallei infection. Use of the proteins in treating Burkholderia mallei or Burkholderia pseudomallei infection and uses in the preparation of vaccines against melioidosis and glanders are described and claimed.

Source: FreshPatents
 

Present and future therapeutic strategies for melioidosis and glanders

PDF Print E-mail
Wednesday, 10 March 2010 15:45

Burkholderia pseudomallei and Burkholderia mallei are the causative agents of melioidosis and glanders, respectively. Both Gram-negative pathogens are endemic in many parts of the world. Although natural acquisition of these pathogens is rare in the majority of countries, these bacteria have recently gained much interest because of their potential as bioterrorism agents.

Read more...
 

Renal tubular acidosis presenting as respiratory paralysis: Report of a case and review of literature

PDF Print E-mail
Wednesday, 10 March 2010 15:42

Abstract: Respiratory paralysis due to renal tubular acidosis (RTA) is rare. We report a 22-year-old lady who developed severe bulbar, respiratory and limb paralysis following respiratory infection. She had hypokalemia (1.6 meq/L) and hyperchloremic (110 meq/l) acidosis (pH 7.1).

Read more...
 

WHO unveils landmark anti-malaria measures

PDF Print E-mail
Wednesday, 10 March 2010 15:38
GENEVA — The World Health Organisation unveiled Tuesday landmark new measures to counter the misuse of anti-malaria drugs, which is threatening attempts to stifle some 250 million cases a year of the disease.
Read more...
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 1 of 138
< March 2010 >
M T W T F S S
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31 1 2 3 4

Newsletter



Receive HTML?

What news are you most interested to find in the GMS website?